Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:50 PM
Ignite Modification Date:
2025-12-24 @ 9:50 PM
NCT ID:
NCT05924932
Eligibility Criteria:
Inclusion Criteria:
* patients with T1D
* Type 1 diabetes for \> 1 years
* ≥ 18 years old
* CSII (without HCL) or MDI
Exclusion Criteria:
* Severe noncompliance
* Known severe diabetic retinopathy and/or macular edema,
* Lactation, pregnancy, or intending to become pregnant during the study;
* A condition likely to require MRI. Use of acetaminophen-containing medication;
* Unwillingness to use the study device for \>70% of time.
* Conditions that affect red blood cell turnover (hemolytic and other anemias, glucose-6-phosphate dehydrogenase deficiency, recent blood transfusion, use of drugs that stimulate erythropoesis, end-stage kidney disease).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05924932
Study Brief:
Protocol Section:
NCT05924932